Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia
- PMID: 9100623
- DOI: 10.1016/s0140-6736(96)08295-5
Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia
Abstract
Background: Conservative outpatient therapy for cervical intraepithelial neoplasia (CIN) by ablative or excisional techniques is widely used. The main objective of this treatment is the prevention of invasive cervical cancer. We assessed the rate of invasive disease and the duration of the risk of developing invasive cervical cancer after such treatment.
Methods: Four UK centres have used life-table methods to analyse the long-term results of conservative treatment of CIN. We combined and updated data from these studies to investigate the rate of invasive disease after treatment and the duration of that risk.
Findings: The data comprised 44 699 woman-years of follow-up, with 2116 women under observation 8 years after treatment. 33 women developed invasive cancer, 14 of whom had microinvasion. The cumulative rate of invasion 8 years after treatment was 5.8 per 1000 women and the rate of invasive cancer during this period was 85 (95% CI 60-119) per 100,000 woman-years. The risk of developing cancer did not change throughout the 8 years of follow-up.
Interpretation: These data show that conservative outpatient therapy in women with CIN reduces the risk of invasive cancer of the cervix by 95% during the first 8 years after treatment. However, even with careful, long-term follow-up, the risk of invasive cervical cancer among these women is about five times greater than that among the general population of women throughout that period. Careful follow-up is essential for at least 10 years after conservative treatment of CIN.
Comment in
-
Invasive potential of carcinoma in situ of the cervix.Lancet. 1997 Apr 5;349(9057):967. doi: 10.1016/S0140-6736(05)62887-5. Lancet. 1997. PMID: 9100618 No abstract available.
-
Invasive cervical cancer after treatment for cervical intraepithelial neoplasia.Lancet. 1997 Jun 28;349(9069):1909. doi: 10.1016/S0140-6736(97)26026-5. Lancet. 1997. PMID: 9217773 No abstract available.
-
Invasive cervical cancer after treatment for cervical intraepithelial neoplasia.Lancet. 1997 Jun 28;349(9069):1909-10. doi: 10.1016/S0140-6736(05)63903-7. Lancet. 1997. PMID: 9217774 No abstract available.
-
Invasive cervical cancer after treatment for cervical intraepithelial neoplasia.Lancet. 1997 Jun 28;349(9069):1910. doi: 10.1016/s0140-6736(05)63904-9. Lancet. 1997. PMID: 9217775 No abstract available.
Similar articles
-
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study.J Natl Cancer Inst. 2009 May 20;101(10):721-8. doi: 10.1093/jnci/djp089. Epub 2009 May 12. J Natl Cancer Inst. 2009. PMID: 19436026 Free PMC article.
-
Invasive cancer after treatment of cervical intraepithelial neoplasia.Ann Acad Med Singap. 1998 Sep;27(5):722-4. Ann Acad Med Singap. 1998. PMID: 9919349
-
Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III.Eur J Cancer. 2012 Apr;48(6):845-52. doi: 10.1016/j.ejca.2011.05.002. Eur J Cancer. 2012. PMID: 21658934
-
Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.Int J Cancer. 2006 Apr 15;118(8):2048-55. doi: 10.1002/ijc.21604. Int J Cancer. 2006. PMID: 16284947 Review.
-
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.J Low Genit Tract Dis. 2007 Oct;11(4):223-39. doi: 10.1097/LGT.0b013e318159408b. J Low Genit Tract Dis. 2007. PMID: 17917567
Cited by
-
Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.BMJ. 2007 Nov 24;335(7629):1077. doi: 10.1136/bmj.39363.471806.BE. Epub 2007 Oct 24. BMJ. 2007. PMID: 17959735 Free PMC article.
-
Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.BMC Womens Health. 2017 Jan 7;17(1):2. doi: 10.1186/s12905-016-0355-x. BMC Womens Health. 2017. PMID: 28061842 Free PMC article. Clinical Trial.
-
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.Cochrane Database Syst Rev. 2014 Apr 9;2014(4):CD004121. doi: 10.1002/14651858.CD004121.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Feb 12;2:CD004121. doi: 10.1002/14651858.CD004121.pub4. PMID: 24715225 Free PMC article. Updated.
-
Clinical significance of HPV-DNA testing for precancerous cervical lesions.J Med Life. 2014;7 Spec No. 3(Spec Iss 3):37-9. J Med Life. 2014. PMID: 25870692 Free PMC article.
-
Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.J Gynecol Oncol. 2009 Jun;20(2):86-90. doi: 10.3802/jgo.2009.20.2.86. Epub 2009 Jun 29. J Gynecol Oncol. 2009. PMID: 19590718 Free PMC article.